Chronic Fatigue Syndrome Clinical Trial
Official title:
ME/CFS: Activity Patterns and Autonomic Dysfunction
The purpose of this study is to identify daily activity patterns, negative life events and autonomic abnormalities that may be related to non-improvement in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). For both naturalistic studies and behavioral intervention trials, roughly 50% of patients report worsening or unchanged illness. The proposed four year study would be the first to look at the relation between illness non-improvement, patient activities at home and autonomic function. Our long-range goal is to identify physiological signals and activity patterns that predict non-improvement and relapse and develop a self-management program that prescribes improvement-linked behaviors and discourages non-improvement activities.
Given the enduring debilitation and poor quality of life in ME/CFS, this study proposes to
identify important activity patterns (e.g., push-crash), negative life events and autonomic
dysfunction that may be associated with non-improvement. This will be accomplished with
weekly online diaries, objective measures (actigraphy, heart rate monitors) and
semi-structured phone interviews. Non-improvement is a rarely studied, but commonly reported
outcome in this illness. For both naturalistic studies and behavioral intervention trials,
roughly 50% of ME/CFS patients report worsening or unchanged illness. Also, the patient's
self-management efforts may (paradoxically) produce symptom worsening and contribute to
illness non-improvement. Non-improvement may also have biological relevance because activity
limitations and sleep disruption in ME/CFS have both been associated with autonomic
dysregulation (reduced heart rate variability). This (R01) prospective observational six
month study of both daily and weekly in vivo assessments would be the first to look at
non-improvement in relation to ongoing patient activities and autonomic function.
Specific Aim 1: To assess the relation between non-improvement and prospectively assessed
activity patterns and life events. Hypothesis 1: Non-improvement will be significantly
associated with these dimensional variables: (a) illness-exacerbating activity patterns
(e.g., "push-crash") reported on home web diaries; (b) daily hassles assessed in web
diaries; and (c) negative life events reported in phone interviews.
Specific Aim 2: To assess the relation between improvement and prospectively assessed
activity patterns and life events. Hypothesis 2: Improvement will be significantly
associated with: (a) illness-moderating activity patterns (e.g., healthy pacing) reported on
home web diaries; (b) daily uplifts assessed in web diaries; and (c) positive life events
assessed in phone interviews.
Specific Aim 3: To assess the relation between activity patterns and symptoms. Hypothesis 3:
(a) the "push-crash" pattern will predict greater actigraphy variability and symptom
variability; (b) the "limiting activity" pattern will be associated with very low actigraphy
counts and high symptom severity; and (c) a healthier "pacing" pattern will be associated
with moderate variability of actigraphy and symptoms.
Our secondary aim hypothesizes that autonomic dysregulation (reduced heart rate variability
[HRV]) will be characteristic of both non-improvers and patients with a limiting activity
pattern as compared to improvers and those with a healthy pacing pattern. The long-range
goal is to develop a new self-management protocol that more clearly identifies
non-improvement activities and how they can be changed. An important aspect of this new
self-management protocol would be to identify early signals of impending relapse,
particularly HRV status, via home-use portable devices that could be utilized by patients
and their doctors as a warning to modify non-improvement activities, e.g., excessive
activity or exercise, to prevent behavioral collapse into inactivity.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05454683 -
Melatonin and Zinc Administration on Cardinal Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
|
N/A | |
Completed |
NCT02075489 -
Acupressure for Pain Management and Fatigue Relief in Gulf War Veterans
|
N/A | |
Completed |
NCT01686074 -
Motor Control in Chronic Fatigue Syndrome and Fibromyalgia
|
N/A | |
Completed |
NCT01651754 -
Humoral and Cellular Immune Responses After Influenza Vaccination in Patients With Postcancer Fatigue and in Patients With Chronic Fatigue Syndrome
|
N/A | |
Completed |
NCT00540254 -
Behavioral Insomnia Therapy With Chronic Fatigue Syndrome
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT00071162 -
Genetics of Fibromyalgia
|
N/A | |
Withdrawn |
NCT04870476 -
Feasibility and Acceptability of the Internet-delivered Treatment "One Step at the Time" for Bodily Distress Syndrome
|
N/A | |
Completed |
NCT05730660 -
Quercetin Phytosome® Chronic Fatigue Syndrome
|
N/A | |
Recruiting |
NCT04542161 -
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
|
Phase 2 | |
Recruiting |
NCT03807973 -
Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes.
|
Phase 1 | |
Recruiting |
NCT05719493 -
Effectiveness and Health Benefits of a Nutritional, Chronobiological and Physical Exercise Intervention in Fibromyalgia and Chronic Fatigue Syndrome (SYNCHRONIZE +)
|
N/A | |
Recruiting |
NCT05967052 -
Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation
|
Phase 2 | |
Terminated |
NCT01730495 -
Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
|
Phase 2 | |
Completed |
NCT01156909 -
B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
|
Phase 2 | |
Completed |
NCT01650636 -
Patient-Partner Stress Management Effects on Chronic Fatigue Syndrome Symptoms and Neuroimmune Process
|
N/A | |
Completed |
NCT01046370 -
A Pilot Study of Amygdala Retraining Program in Patients With Chronic Fatigue Syndrome, Chronic Fatigue and Fibromyalgia
|
N/A | |
Completed |
NCT00100412 -
Hyporeactivity and Gulf War Illness
|
N/A | |
Recruiting |
NCT06128967 -
A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial
|
Phase 3 | |
Completed |
NCT02669212 -
Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health
|
N/A | |
Not yet recruiting |
NCT06011135 -
Exploring Worry in CFS/ME
|